Cited by 278Bone Metabolism and DiseasesTGF-β signaling in diseasesRheumatoid Arthritis Research and Therapies

Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions

Quinn, Julian M. W., Itoh, Kanami, Udagawa, Nobuyuki, Häusler, Karl, Yasuda, Hisataka, Shima, Nobuyuki, Mizuno, Atsuko, Higashio, Kanji +4 more·2001·Journal of Bone and Mineral Research

Abstract

Transforming growth factor beta (TGF-beta) is abundant in bone and has complex effects on osteolysis, with both positive and negative effects on osteoclast differentiation, suggesting that it acts via more than one mechanism. Osteoclastogenesis is determined primarily by osteoblast (OB) expression of the tumor necrosis factor (TNF)-related molecule receptor activator of NF-kappaB ligand (RANKL) and its decoy receptor osteoprotegerin (OPG), which are increased and decreased, respectively, by osteolytic factors. A RANKL-independent osteoclastogenic mechanism mediated by TNF-alpha has also been shown. Therefore, we investigated TGF-beta effects on osteoclast formation in culture systems in which osteoclastogenic stimulus is dependent on OBs and culture systems where it was provided by exogenously added RANKL or TNF-alpha. Both OPG and TGF-beta inhibited osteoclast formation in hemopoietic cell/OB cocultures, but the kinetics of their action differed. TGF-beta also inhibited osteoclastogenesis in cocultures of cells derived from OPG null (opg-/-) mice. TGF-beta strongly decreased RANKL messenger RNA (mRNA) expression in cultured osteoblasts, and addition of exogenous RANKL to TGFbeta-inhibited cocultures of opg-/- cells partially restored osteoclastogenesis. Combined, these data indicate that the inhibitory actions of TGF-beta were mediated mainly by decreased OB production of RANKL. In contrast, in the absence of OBs, TGF-beta greatly increased osteoclast formation in recombinan…

Integrity signals

Registry

Crossref · 10.1359/jbmr.2001.16.10.1787

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TGF-β, released from the bone matrix during bone resorption, enhances osteoclast differentiation in RANKL- and M-CSF-stimulated HSC cultures.

    “Transforming growth factor-β, which is released from the bone matrix during bone resorption, has been shown to enhance osteoclast differentiation in RANKL- and M-CSF-stimulated HSC cultures [35].”

    From Osteoclasts and Microgravity (2020) · cites this paper as [35]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Quinn, J. M. W., Itoh, K., Udagawa, N., Häusler, K., Yasuda, H., Shima, N., Mizuno, A., Higashio, K., Takahashi, N., Suda, T., Martin, T. J., & Gillespie, M. T.
Affiliations
  • The University of Melbourne (AU)
  • SHOWA Medical University (JP)
  • Department of Medicine, St. Vincent's Institute of Medical Research and The University of Melbourne, Fitzroy, Victoria, Australia
  • Megmilk Snow Brand (Japan) (JP)
Corresponding author
Quinn, Julian M. W.
Venue
Journal of Bone and Mineral Research
Published
2001-10-01
Volume
16
Issue
10
Pages
1787-1794
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2065784567
Cited by
278
References
3
Citations by year
2026: 2 · 2025: 9 · 2024: 9 · 2023: 7 · 2022: 9 · 2021: 11 · 2020: 14 · 2019: 13 · 2018: 4 · 2017: 13 · 2016: 7 · 2015: 12 · 2014: 15 · 2013: 10 · 2012: 8
FWCI
4.31
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Bone and Mineral Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
TGF-beta, osteoclastogenesis, RANKL, osteoprotegerin, TNF-α, osteoblasts, osteolysis, osteoclast precursors, bone remodeling
MeSH terms
Animals, Carrier Proteins, Cell Differentiation, Cells, Cultured, Glycoproteins, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Spleen, Tumor Necrosis Factor-alpha, Transforming Growth Factor beta, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Mice, Knockout, Coculture Techniques, Mice, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review